[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337751-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-337751-en":135},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","untargeted-metabolomics-in-gastric-and-colorectal-cancer-patients-preliminary-results","Untargeted metabolomics in gastric and colorectal cancer patients - preliminary results","","Untargeted metabolomics was applied to analyze the gut metabolome in gastrointestinal cancer patients, focusing on gastric and colorectal cancer. Twelve patients were enrolled (4 gastric, 8 colorectal) with 8 analyzed (4 each), and stool samples were collected prior to anti-cancer treatments. Mass spectrometry profiling revealed a broad range of metabolites, with greater metabolite homogeneity in gastric cancer. Several metabolites showed significant level differences between cancer types, suggesting distinct gut metabolomic patterns. Overall findings indicated higher metabolite levels in colorectal cancer, warranting confirmation in larger multi-center studies.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/untargeted-metabolomics-in-gastric-and-colorectal-cancer-patients-preliminary-results/337751/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/untargeted-metabolomics-in-gastric-and-colorectal-cancer-patients-preliminary-results/337751.png","ImageObject",300,407,{"name":42,"@type":43},"Eliana","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study’s main objective?","Question",{"text":63,"@type":64},"To analyze the gut untargeted metabolome in gastrointestinal cancer patients, specifically gastric and colorectal cancer, using stool-based metabolomics.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were patients and stool samples handled?",{"text":68,"@type":64},"Twelve patients were enrolled (4 gastric, 8 colorectal) and 8 were analyzed (4 each). Stool samples were collected prior to any anti-cancer treatments.",{"name":70,"@type":61,"acceptedAnswer":71},"What method was used for metabolomics analysis?",{"text":72,"@type":64},"Untargeted metabolomics analyses were conducted using mass spectrometry.",{"name":74,"@type":61,"acceptedAnswer":75},"What key conclusion was drawn from the results?",{"text":76,"@type":64},"Colorectal cancer patients showed higher levels of most analyzed metabolites compared with gastric cancer patients, though links to metastasis require validation in larger multi-center studies.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},337751,1790128251,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,124,127,131],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":122,"slug":123},9,"Religion & Spirituality",20,"religion-spirituality",{"id":122,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":122,"slug":126},"World Cup","world-cup",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":128,"slug":130},10,"Lifestyle","lifestyle",{"id":132,"doc_module":4,"doc_module_name":25,"category_name":133,"show_sort_weight":101,"slug":134},19,"General","general",{"code":4,"msg":86,"data":136},{"doc_id":83,"user_id":137,"nickname":42,"user_avatar":138,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":128,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":149,"preview_page_count":33,"preview_urls":150},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","TYPE Original Research PUBLISHED 07 May 2024  \nDOI 10.3389/fcimb.2024.1394038  \nOPEN ACCESS  \nEDITED BY  \nAmedeo Amedei, University of Florence, Italy  \nREVIEWED BY  \nAnna Duda-Madej,  \nWroclaw Medical University, Poland Yotsawat Pomyen,  \nChulabhorn Research Institute, Thailand  \n*CORRESPONDENCE  \nKarolina Kaz´mierczak-Siedlecka  \n [leokadia@gumed.edu.pl](leokadia@gumed.edu.pl)[ ](leokadia@gumed.edu.pl)Leszek Kalinowski  \n [leszek.kalinowski@gumed.edu.pl](leszek.kalinowski@gumed.edu.pl)[ ](leszek.kalinowski@gumed.edu.pl)Ewa Stachowska  \n [ewa.stachowska@pum.edu.pl](ewa.stachowska@pum.edu.pl)  \nRECEIVED 29 February 2024  \nACCEPTED 08 April 2024  \nPUBLISHED 07 May 2024  \nCITATION  \nKaz´mierczak-Siedlecka K, Muszyn´ski D, Styburski D, Makarewicz J, Sobocki BK, Ulasin´ski P, Połom K, Stachowska E, Skonieczna-Z˙ydecka K and Kalinowski L (2024) Untargeted metabolomicsin gastric and colorectal cancer patients – preliminary results.  \nFront. Cell. Infect. Microbiol. 14:1394038 .  \ndoi: 10.3389/fcimb.2024.1394038  \nCOPYRIGHT  \n© 2024 Kaz´mierczak-Siedlecka, Muszyn´ski, Styburski, Makarewicz, Sobocki, Ulasin´ski, Połom, Stachowska, Skonieczna-Z˙ydecka and Kalinowski. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nUntargeted metabolomics in gastric and colorectal cancer patients – preliminary results  \nKarolina Ka´zmierczak-Siedlecka 1*, Damian Muszy ´nski 2, Daniel Styburski 3, Jakub Makarewicz 2, Bartosz Kamil Sobocki 4, Paweł Ulasi ´nski 5, Karol Połom 6,7,8, Ewa Stachowska 9*, Karolina Skonieczna- ˙Zydecka 10 and Leszek Kalinowski 1,11*  \n1Department of Medical Laboratory Diagnostics – Fahrenheit Biobank [BBMRI.pl](BBMRI.pl), Medical University of Gdansk, Gdansk, Poland, 2Scientiﬁc Circle of Studies Regarding Personalized Medicine Associated with Department of Medical Laboratory Diagnostics, Medical University of Gdansk, Gdansk, Poland, 3Sanprobi Sp. z o. o., Szczecin, Poland, 4 Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland, 5 Unit of Surgery with Unit of Surgery with Unit of Oncological Surgery, Specialist Hospital in Koscierzyna, Koscierzyna, Poland, 6Academy of Medical and Social Applied Sciences, Elblg, Poland, 7 Department of Surgical Oncology, Medical University of Gdansk, Gdansk, Poland, 8 Department of Gastrointestinal Surgical Oncology, Greater Poland Cancer Centre, Poznan, Poland, 9 Department of Human Nutrition and Metabolomics, Pomeranian Medical University in Szczecin, Szczecin, Poland, 10 Department of Biochemical Research, Pomeranian Medical University in Szczecin, Szczecin, Poland, 11 BioTechMed Centre/Department of Mechanics of Materials and Structures, Gdansk University of Technology, Gdansk, Poland  \nIntroduction: Recent years, microbiota-associated aspects have been analysed in multiple disorders regarding cancers . Existing evidence pints that gut microorganisms might take part in tumour origin and therapy efﬁcacy. Nevertheless, to date, data on faecal metabolomics in cancer patients is still strongly limited. Therefore, we aimed to analyse gut untargeted metabolome in gastrointestinal cancer patients (i. e., gastric and colorectal cancer) .  \nPatients and methods: There were 12 patients with either gastric (n=4) or colorectal cancer (n=8) enrolled and 8 analysed (n=4 each) . Stool samples were collected prior to anti-cancer treatments. Untargeted metabolomics analyses were conducted by means of mass spectrometry.  \nResults: A plethora of metabolites in cancer patients we analysed were noted, with higher homogenity in case of gastric cancer patients. We found that the level o","cbCairexfBD9Hsqp","https://ap.wps.com/l/cbCairexfBD9Hsqp","pdf",1626595,"English","# Introduction\n# Patients and methods\n# Results\n# Conclusion\n# Keywords","[{\"question\":\"What is the study’s main objective?\",\"answer\":\"To analyze the gut untargeted metabolome in gastrointestinal cancer patients, specifically gastric and colorectal cancer, using stool-based metabolomics.\"},{\"question\":\"How were patients and stool samples handled?\",\"answer\":\"Twelve patients were enrolled (4 gastric, 8 colorectal) and 8 were analyzed (4 each). Stool samples were collected prior to any anti-cancer treatments.\"},{\"question\":\"What method was used for metabolomics analysis?\",\"answer\":\"Untargeted metabolomics analyses were conducted using mass spectrometry.\"},{\"question\":\"What key conclusion was drawn from the results?\",\"answer\":\"Colorectal cancer patients showed higher levels of most analyzed metabolites compared with gastric cancer patients, though links to metastasis require validation in larger multi-center studies.\"}]","Untargeted metabolomics in gastric and colorectal cancer patients - preliminary results | PDF",1790020483,25,[151,155,159,163],{"page_no":22,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/463bcbf1c6fad49dcda889d9e7e3f7a8.webp",983,1389,{"page_no":26,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f407ee29bd03243c0b9a829aa8775762.webp",982,1388,{"page_no":30,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/97fa295ba334266338363546a8ed4e96.webp",981,1386,{"page_no":33,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb534c579cf5c82ba29a49268b3367b3.webp",980,1385]